Peritoneal Carcinomatosis
Watchlist
Retrieved
2021-01-18
Source
Trials
—
Genes
CTNNB1,
WT1,
IGF2BP3,
CALB2,
PDPN,
MLANA,
MUC1,
SLC2A1,
MCAM,
VIM,
TWIST1,
CEACAM5,
SERPINA5,
CEACAM7,
SMUG1,
PSG2,
CEACAM3,
TGFB1,
TP53,
CXCR4,
CXCL12,
KRAS,
EPCAM,
NR1I3,
NPEPPS,
SLC16A4,
MET,
SLC16A3,
PGK1,
PLAG1
CTNNB1,
WT1,
IGF2BP3,
CALB2,
PDPN,
MLANA,
MUC1,
SLC2A1,
MCAM,
VIM,
TWIST1,
CEACAM5,
SERPINA5,
CEACAM7,
SMUG1,
PSG2,
CEACAM3,
TGFB1,
TP53,
CXCR4,
CXCL12,
KRAS,
EPCAM,
NR1I3,
NPEPPS,
SLC16A4,
MET,
SLC16A3,
PGK1,
PLAG1,
PRKAR1A,
PROS1,
SPG7,
IFNG,
HGF,
CXADRP1,
CASR,
ESR2,
KLK3,
TRIM13,
CXADR,
BRCA1,
ARR3,
BRCA2,
PSAT1,
COL18A1,
PROKR2,
MUC16,
TRIM28,
CLEC4D,
TSPY3,
VEGFA,
TSPY1,
IL33,
GEMIN2,
DCLK3,
BAP1,
PROK1,
SOCS1,
CFLAR,
DCDC2,
GPKOW,
B3GAT1,
SCAF11,
HPS5,
SLC9A3R2,
ZEB2,
AGTR1,
PIK3CA,
TGFBI,
CD80,
EGFR,
HBEGF,
ATN1,
CTLA4,
CDKN3,
CDKN2A,
CD86,
CD8A,
TFAP2A,
C1QBP,
BRAF,
BNIP3L,
BNIP3,
BDNF,
ATF3,
AREG,
FGFR2,
MTOR,
FSHR,
IL2RG,
TAC1,
SST,
SSAV1,
RPS6KB1,
REV3L,
AMBP,
PF4,
OPRM1,
NTRK2,
MMP2,
MLH1,
SMAD2,
KLRC1,
KDR,
ING2,
TSPY10
Drugs
—
Registered!
Peritoneal carcinomatosis (PC) is intraperitoneal dissemination (carcinosis) of any form of cancer that does not originate from the peritoneum itself. PC is most commonly seen in abdominopelvic malignancies. Computed tomography (CT) is particularly important for detailed preoperative assessment and evaluation of the radiological Peritoneal Cancer Index (PCI).